Letter to the Editor Regarding: “Real-World Effectiveness of a Third Dose of mRNA-1273 Versus BNT162b2 on Inpatient and Medically Attended COVID-19 Among Immunocompromised US Adults”.

Publication date: Nov 01, 2024

Open Access PDF

Concepts Keywords
Adults Adults
Bnt162b2 Attended
Immunocompromised Covid
Mrna Dis
Dose
Editor
Effectiveness
Immunocompromised
Infect
Inpatient
Letter
Mrna
Real
Ther
World

Semantics

Type Source Name
disease MESH COVID-19

Original Article

(Visited 1 times, 1 visits today)